Chemicals and pharmaceuticals · EGRX

EAGLE PHARMACEUTICALS, INC.

12 filings mentioning 6 of the compliance and risk topics we track. Every row links to the filing on EDGAR.

12filings we hold
6topics disclosed
Chemicals and pharmaceuticalsindustry
NJbased in

Across 12 filings we hold, EAGLE PHARMACEUTICALS, INC. has written down 6 of the topics we track. That places it 25 of 737 companies we hold in chemicals and pharmaceuticals, by how much we have collected.

EGRX Chemicals and pharmaceuticals

What this obligates

Every instrument in our corpus that governs something EAGLE PHARMACEUTICALS, INC. has written into a filing. Not what they said. What applies once they have said it.

NIST Cybersecurity Framework 2.078
ISO 27001:202242
ASD Strategies to Mitigate Cyber Security Incidents29
GDPR26
ISO/IEC 27701:201921
Code of Conduct on Data Protection for Research (GDPR Article 40)12
COSO Internal Control9
EU Data Governance Act (DGA)7
Basel III International Banking Framework6
NIST SP 800-615

10 frameworks, 235 controls between them, deduplicated across topics.

What it discloses

Tracked topics appearing in this company's filings, most frequent first.

Internal Control20
Restatement14
Regulatory Reporting2
Cross Border Data Transfer2
Data Residency2
Ransomware2

Bars are scaled against this company's most frequent topic, not against the market. The table below has the exact counts.

TopicFilingsMost recent
Internal Control202024-11-27
Restatement142024-11-27
Regulatory Reporting22020-05-11
Cross Border Data Transfer22023-03-23
Data Residency22023-03-23
Ransomware22023-03-23

When it filed

Filings we hold, by year. Hover a bar for the count.

20
21
22
23
24

Recent filings

FiledFormItem
2024-11-278-KChange of accountant, Financial statements and exhibitsfiling
2024-11-158-KDelisting or listing rule failurefiling
2024-11-128-KDirector or officer departure, Regulation FD disclosure, Other material eventfiling
2024-10-318-KEntry into a material agreement, Item 3.03, Item 5.03filing
2024-10-028-KResults of operations, the earnings release, Delisting or listing rule failure, Financial statements no longer reliablefiling
2024-08-278-KEntry into a material agreement, Item 2.03, Delisting or listing rule failurefiling
2024-08-058-KOther material eventfiling
2024-07-108-KEntry into a material agreementfiling
2024-05-298-KOther material eventfiling
2024-05-228-KDelisting or listing rule failure, Regulation FD disclosure, Financial statements and exhibitsfiling
2024-05-158-KEntry into a material agreement, Financial statements and exhibitsfiling
2024-04-128-KDelisting or listing rule failure, Regulation FD disclosure, Financial statements and exhibitsfiling

Others in chemicals and pharmaceuticals

The companies we hold most on in the same industry. Each opens side by side with this one.

CompanyFilings
OPKOPKO HEALTH, INC.12compare →
FGENFIBROGEN INC12compare →
PTNPALATIN TECHNOLOGIES INC12compare →
OTLCOncotelic Therapeutics, Inc.12compare →
NKTRNEKTAR THERAPEUTICS12compare →
APALEXION PHARMACEUTICALS, INC.12compare →
New here? Signals tracks the compliance and risk language public companies put into their SEC filings, and cross-references it against 723 frameworks and 20,473 controls. See what moved today or check how much of a framework you already cover.

What this page is

Every row comes from SEC full-text search over this company's filings, matched against the compliance and risk phrases we track. It is a record of what the company itself wrote down in documents it is legally accountable for. It is not an assessment of the company, a rating, or a claim about how well it manages anything.

A phrase appearing in a filing frequently means the risk section mentions it, not that an event occurred. Where an item number indicates an actual event, the Item column says so.

All of chemicals and pharmaceuticals · All companies · Today's edition